$28,450,000 is 5% royalty per year of $569,000,000 in sales of JZP-386.
$28,450,000 doesn't sound like much, but it is considering it's pure profit and considering the current market cap size of CNCE. And if the royalty percent is higher, that's more money.
Anything helps. I am more interested in the upcoming ctp-499 partnership? It has to be a big pharma. Who is it going to be?